Compare Enbridge Inc (ENB) vs Figs Inc (FIGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enbridge Inc vs Figs Inc — how do they compare? Enbridge Inc trades at $46.54 (market cap $103.38B), while Figs Inc trades at $14.96 (market cap $2.49B). The key difference: Enbridge Inc is far larger — about 41.5× Figs Inc's market cap, and Enbridge Inc pays a 6.02% dividend while Figs Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enbridge Inc for 91 Days and Figs Inc for 33 Days on average.
| ENB | FIGS | |
|---|---|---|
Market Cap | $103.38B | $2.49B |
Volume | 3,684,305 | 5,964,311 |
Sector | Energy | Consumer Cyclical |
52-Week High | $58.04 | $17.12 |
52-Week Low | $45.23 | $6.90 |
Typical Hold Time | 91 Days | 33 Days |
Enterprise Value | $185.39B | $2.25B |
Dividend Yield | 6.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enbridge (ENB) trades at $45.89, down 1.4% with bearish technical signals despite strong fundamentals. The company reported Q2 2026 EPS of $0.46, beating expectations by 7%, and maintains a 6% dividend yield. Revenue grew to $65.19B in 2025 with net income of $7.49B, though 2026 projections show margin compression. Analyst consensus is mixed with 48% buy ratings and a $61.63 price target suggesting 34% upside potential.
ENB presents a value opportunity with discounted valuation metrics (P/E 25.27, P/S 1.72) and stable cash flows, but faces headwinds from rising interest rates and energy market volatility. The stock's current technical weakness contrasts with fundamental strength, creating potential for recovery if operational execution continues to outperform expectations.
FIGS trades at $14.06, down 0.28% today, with a bullish technical signal from moving averages. The company shows strong revenue growth from $556M in 2024 to $631M in 2025, with net income surging to $34M. Recent quarters have consistently beaten EPS expectations, and international sales grew 67% in Q2 2026. Analyst consensus is bullish with a $18.00 price target suggesting 28% upside potential from current levels.
The outlook remains positive with accelerating growth and margin expansion, though the stock's rich valuation (P/E 42.6) presents risk if execution falters. Key catalysts include continued international expansion and sustained demand from healthcare professionals, while risks include premium valuation pressure and competitive threats in medical apparel.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enbridge Inc
Enbridge owns extensive midstream assets that transport hydrocarbons across the U.S. and Canada. Its pipeline network consists of the Canadian Mainline system, regional oil sands pipelines, and natural gas pipelines. The company also owns and operates a regulated natural gas utility and Canada's largest natural gas distribution company. Finally, the firm has a small renewables portfolio primarily focused on onshore and offshore wind projects.
Read more on ENB →About Figs Inc
FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →
